July 1, 2007 Journal article Open Access

Wu, Kuei-Meng; Farrelly, James G.

JSON-LD (schema.org) Export

{
  "description": "n/a", 
  "license": "https://creativecommons.org/publicdomain/zero/1.0/legalcode", 
  "creator": [
    {
      "@type": "Person", 
      "name": "Wu, Kuei-Meng"
    }, 
    {
      "@type": "Person", 
      "name": "Farrelly, James G."
    }
  ], 
  "headline": "Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2007-07-01", 
  "url": "https://zenodo.org/record/1259393", 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.1016/j.tox.2007.04.005", 
  "@id": "https://doi.org/10.1016/j.tox.2007.04.005", 
  "@type": "ScholarlyArticle", 
  "name": "Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology"
}